Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Targeted Analysis of Serum Proteins Encoded at Known Inflammatory Bowel Disease Risk Loci

Research output: Contribution to journalJournal articleResearchpeer-review


  1. Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease: A Double-Center Cohort Study

    Research output: Contribution to journalLetterpeer-review

  2. A 10-Year Follow-up Study of the Natural History of Perianal Crohn's Disease in a Danish Population-Based Inception Cohort

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Indications and diagnostic yield of small-bowel capsule endoscopy in a real-world setting

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Glucagon-Like Peptide-2 Analogue ZP1849 Augments Colonic Anastomotic Wound Healing

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Kimi Drobin
  • Ghazaleh Assadi
  • Mun-Gwan Hong
  • Eni Andersson
  • Claudia Fredolini
  • Björn Forsström
  • Anna Reznichenko
  • Tahmina Akhter
  • Weronica E Ek
  • Ferdinando Bonfiglio
  • Mark Berner Hansen
  • Kristian Sandberg
  • Dario Greco
  • Dirk Repsilber
  • Jochen M Schwenk
  • Mauro D'Amato
  • Jonas Halfvarson
View graph of relations

Background Few studies have investigated the blood proteome of inflammatory bowel disease (IBD). We characterized the serum abundance of proteins encoded at 163 known IBD risk loci and tested these proteins for their biomarker discovery potential. Methods Based on the Human Protein Atlas (HPA) antibody availability, 218 proteins from genes mapping at 163 IBD risk loci were selected. Targeted serum protein profiles from 49 Crohn's disease (CD) patients, 51 ulcerative colitis (UC) patients, and 50 sex- and age-matched healthy individuals were obtained using multiplexed antibody suspension bead array assays. Differences in relative serum abundance levels between disease groups and controls were examined. Replication was attempted for CD-UC comparisons (including disease subtypes) by including 64 additional patients (33 CD and 31 UC). Antibodies targeting a potentially novel risk protein were validated by paired antibodies, Western blot, immuno-capture mass spectrometry, and epitope mapping. Results By univariate analysis, 13 proteins mostly related to neutrophil, T-cell, and B-cell activation and function were differentially expressed in IBD patients vs healthy controls, 3 in CD patients vs healthy controls and 2 in UC patients vs healthy controls (q < 0.01). Multivariate analyses further differentiated disease groups from healthy controls and CD subtypes from UC (P < 0.05). Extended characterization of an antibody targeting a novel, discriminative serum marker, the laccase (multicopper oxidoreductase) domain containing 1 (LACC1) protein, provided evidence for antibody on-target specificity. Conclusions Using affinity proteomics, we identified a set of IBD-associated serum proteins encoded at IBD risk loci. These candidate proteins hold the potential to be exploited as diagnostic biomarkers of IBD.

Original languageEnglish
JournalInflammatory Bowel Diseases
Issue number2
Pages (from-to)306-316
Number of pages11
Publication statusPublished - 10 Jan 2019

    Research areas

  • affinity proteomics, inflammatory bowel disease, LACC1

ID: 56169908